从国际期刊论文发表看我国药理学研究  

Insight into pharmacological research in China through analysis of international articles

作　　者：赵颖[1,2] 穆鑫[1,2] 阿丽塔[3] 李阳[3] 王昕[2,4] 唐小利[3] 张永祥[2,5] 杜冠华[1,2] 

机构地区：[1]中国医学科学院北京协和医学院药物研究所,北京100050 [2]中国药理学会,北京100050 [3]中国医学科学院医学信息研究所,北京100005 [4]北京大学医学部,北京100191 [5]军事医学科学院毒物药物研究所,北京100850

出　　处：《中国药理学与毒理学杂志》2014年第6期952-956,共5页Chinese Journal of Pharmacology and Toxicology

基　　金：中国科学技术协会学会能力提升专项-优秀科技社团奖~~

摘　　要：选择2012版汤森路透科学引证报告自然科学版中药理学源学科222种期刊检索,从学科分类、研究对象和地区、机构分布的角度,通过分析2013年中国药理学工作者在国际学术期刊中发表的论文情况,对我国药理学发展的现状、问题及趋势进行总结与分析。2013年,中国学者参与发表的药理学国际期刊文章共5090篇。学科分布与社会疾病发生率关系密切,基础研究占比重较大,而临床研究水平有待提高。地域、机构分布集中性明显且与科技经费投入密切相关。我国药理学研究已进入快速发展阶段,将继续以威胁人类的重大疾病为重点目标,加强基础与临床药理学研究。To explore the current status, problem and development of pharmacology in China by retrieving articles with Chinese authors published in 222 pharmacology related journals from natural science edition of Journal Citation Reports （ R） 2012, Thomson Reuters. Analysis was conducted based on subjects, research objects, and regional and institutional distribution. The results showed that in 2013 there were totally 5090 articles with Chinese authors published in international journals. The hot research objects were closely related to social incidence of disease. Compared to clinical pharmacology, basic pharmacology has become a priority. The regional and institutional distributions were highly concentrated in regions and institutions that had achieved more scientific funds. Pharmacological research in China has entered an era of accelerating development. The main target pharmacological research will be diseases that pose a serious threat to public health. Basic and clinical pharmacology will be strengthened at the same time.

关 键 词：药理学 国际发表 学科分布 

分 类 号：R96[医药卫生—药理学]